Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 44% ± 19% | |
peripheral blood | 18 studies | 37% ± 11% | |
intestine | 11 studies | 40% ± 21% | |
brain | 10 studies | 26% ± 6% | |
kidney | 9 studies | 40% ± 14% | |
eye | 9 studies | 37% ± 18% | |
lymph node | 6 studies | 39% ± 18% | |
liver | 6 studies | 37% ± 24% | |
bone marrow | 5 studies | 30% ± 7% | |
pancreas | 4 studies | 53% ± 19% | |
placenta | 4 studies | 44% ± 25% | |
uterus | 4 studies | 54% ± 16% | |
prostate | 4 studies | 26% ± 10% | |
breast | 4 studies | 44% ± 5% | |
adrenal gland | 3 studies | 34% ± 13% | |
skin | 3 studies | 30% ± 10% | |
thymus | 3 studies | 62% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2752.46 | 459 / 459 | 100% | 301.77 | 1118 / 1118 |
esophagus | 100% | 2625.81 | 1445 / 1445 | 100% | 132.54 | 183 / 183 |
kidney | 100% | 2421.09 | 89 / 89 | 100% | 147.28 | 901 / 901 |
lung | 100% | 2440.76 | 578 / 578 | 100% | 230.65 | 1155 / 1155 |
ovary | 100% | 2700.64 | 180 / 180 | 100% | 226.04 | 430 / 430 |
skin | 100% | 2889.49 | 1809 / 1809 | 100% | 206.80 | 472 / 472 |
stomach | 100% | 1954.75 | 359 / 359 | 100% | 184.83 | 286 / 286 |
thymus | 100% | 2788.17 | 653 / 653 | 100% | 246.67 | 605 / 605 |
uterus | 100% | 3062.11 | 170 / 170 | 100% | 309.91 | 459 / 459 |
brain | 100% | 2511.38 | 2640 / 2642 | 100% | 249.01 | 705 / 705 |
intestine | 100% | 2662.77 | 966 / 966 | 100% | 238.05 | 526 / 527 |
bladder | 100% | 2603.76 | 21 / 21 | 100% | 257.57 | 503 / 504 |
prostate | 100% | 2562.20 | 245 / 245 | 100% | 221.42 | 501 / 502 |
liver | 100% | 1729.08 | 226 / 226 | 100% | 133.43 | 405 / 406 |
adrenal gland | 100% | 3029.59 | 258 / 258 | 99% | 200.39 | 228 / 230 |
pancreas | 98% | 1250.77 | 322 / 328 | 99% | 184.38 | 177 / 178 |
adipose | 100% | 2595.91 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2828.98 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 355.25 | 29 / 29 |
spleen | 100% | 2814.79 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 225.76 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 187.98 | 1 / 1 |
muscle | 99% | 1489.12 | 796 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1736.44 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 135.61 | 79 / 80 |
peripheral blood | 81% | 2573.81 | 751 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006139 | Biological process | nucleobase-containing compound metabolic process |
GO_0006213 | Biological process | pyrimidine nucleoside metabolic process |
GO_0034709 | Cellular component | methylosome |
GO_0030496 | Cellular component | midbody |
GO_0005634 | Cellular component | nucleus |
GO_0008327 | Molecular function | methyl-CpG binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | ERH |
Protein name | Enhancer of rudimentary homolog |
Synonyms | |
Description | FUNCTION: May have a role in the cell cycle. FUNCTION: May have a role in the cell cycle. . |
Accessions | ENST00000557016.6 ENST00000555373.1 P84090 G3V279 |